Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inaamul Haq

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Plos One|November 11, 2020
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional studyS Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
BMJ Open|September 24, 2021
Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020S Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
Frontiers in Public Health|October 24, 2022
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, IndiaKouser Sideeq Lone, S Muhammad Salim Khan, Mariya Amin Qurieshi, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Indian Journal of Medical Research|September 21, 2020
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021Manoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Plos One|November 11, 2020
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional studyS Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
BMJ Open|September 24, 2021
Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020S Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
Frontiers in Public Health|October 24, 2022
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, IndiaKouser Sideeq Lone, S Muhammad Salim Khan, Mariya Amin Qurieshi, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Indian Journal of Medical Research|September 21, 2020
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021Manoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Pageof 6